![]() |
市场调查报告书
商品编码
2000415
建筑生医材料市场预测至2034年-按材料类型、功能、技术、通路、应用、最终用户和地区分類的全球分析Living Materials for Construction Market Forecasts to 2034 - Global Analysis By Material Type, Functionality, Technology, Distribution Channel, Application, End User, and By Geography |
||||||
根据 Stratistics MRC 的数据,预计到 2026 年,全球建筑用生物材料市场规模将达到 11 亿美元,并在预测期内以 14.2% 的复合年增长率增长,到 2034 年将达到 32 亿美元。
用于建筑的生物材料是利用合成生物学、生物技术和先进材料科学设计的生物活性建筑材料,其功能超越了被动的结构作用。这些材料包括利用细菌矿化作用的自修復生物混凝土、菌丝体基复合板、藻类建筑覆材、固碳生物复合材料以及能够自主维持、修復或随时间推移调整自身性能的生物工程结构构件。其主要功能包括自修復能力、碳捕获与储存、温度调节、湿度管理以及在住宅、商业、工业和基础设施建设应用中提高结构耐久性。
碳中和将加速生物材料的应用。
各国纷纷做出净零排放承诺,国际气候变迁协议也要求建设产业履行脱碳义务,这促使人们对能够固碳并主动减少建筑物排放的「活性材料」产生了浓厚的兴趣。光是混凝土生产就占全球二氧化碳排放的约8%,因此,监管和市场对生物相容性替代品的压力日益增加。自修復生物混凝土和固碳生物复合材料具有引人注目的永续性特征,能够满足绿建筑认证和投资者对环境、社会和治理(ESG)的要求。政府采购计画优先考虑低碳建筑材料,以及企业不断增加的净零排放承诺,正在加速实验室创新向商业建筑实用化的转化。
生产规模化和品质稳定性是面临的挑战。
生物材料在生产规模化方面面临巨大挑战,与传统建筑材料相比,商业性竞争力受到严重限制。生物製造工艺,例如菌丝复合复合材料、细菌混凝土和藻类板的生产,需要严格控制的环境条件、较长的生产週期和稳定的质量,这显着增加了製造成本。目前的产量不足以满足主流建筑采购需求,为大型计划开发商带来供应链风险。对于市场参与企业而言,实现稳定的机械性能并符合建筑规范和保险公司要求的标准化认证标准,仍然是一项技术难度高且资源密集的任务。
政府资金支持绿建筑加速商业化
美国、欧盟、英国和新加坡的大规模政府资助项目正透过研发津贴、采购优先政策和创新基础设施示范计划,加速生物建筑材料的商业化进程。例如,美国能源部高级研究计画署(ARPA-E)的「生物启发式建筑材料倡议」和欧盟的「地平线绿色建筑创新丛集」等项目,为处于商业化规模化生产前期的生物材料公司提供了必要的资金和市场准入。具有里程碑意义的公共部门计划将生物建筑材料应用于实践,提高了公众认知度,检验了概念验证(PoC),增强了采购信誉,从而促进了私营部门对生物建筑材料的采用,并吸引了后续的私人投资。
《建筑标准法》下的核准流程会延缓市场进入。
大多数地区的建筑规范和建筑材料标准都基于拥有数十年性能数据的传统无机材料,这为新型生物来源建筑材料的认证设置了重大障碍。结构安全机构要求提供大量的测试数据、长期耐久性数据和标准化的性能基准,而生物材料公司目前仍在累积这些数据。在主要市场获得建筑规范认证可能需要数年时间,这会延缓商业性盈利,并给Start-Ups带来融资负担。此外,结构设计公司和总承包商往往较为保守,在客户计划中采用未经验证的生物来源建筑材料之前,他们会要求这些材料有足够的成功案例。
新冠疫情加剧了建设产业对依赖传统材料所带来的供应链脆弱性的认识,同时也提升了相关人员对永续和循环建筑实践的关注。疫情对传统建筑材料供应链造成的衝击,促使人们接受本地生产的、供应链更短、更具韧性的生物基替代品,例如菌丝复合复合材料和生物混凝土系统。欧洲和北美政府的经济復苏计划,以及强有力的绿色建筑要求,加速了对创新生医材料研发和先导计画的投资。疫情后的环境、社会和治理(ESG)投资指令进一步提升了机构投资者对生物材料作为净零排放建筑策略组成部分的兴趣。
在预测期内,细菌矿化材料细分市场预计将占据最大的市场份额。
在预测期内,细菌矿化材料领域预计将占据最大的市场份额。这主要归功于其成熟且商业性程度高的自修復混凝土应用,这些应用已获得多个司法管辖区的监管核准,并吸引了建设产业的巨额投资。细菌矿化技术具有可衡量的结构修復性能,并有不断增长的临床证据支持,使其成为生物材料领域商业性化程度最高的技术,并有望在预测期内成为主要的收入来源。
在预测期内,自癒功能细分市场预计将呈现最高的复合年增长率。
在预测期内,自修復功能细分市场预计将呈现最高的成长率,这主要得益于监管机构日益增长的压力,旨在降低公共基础设施的生命週期维护成本,以及在人工维护困难或成本过高的应用领域,对自主结构修復的需求不断增长。随着气候变迁加剧建筑物和基础设施的结构荷载,自修復材料的功能正吸引前所未有的投资和规格关注,预计该功能细分市场将在整个预测期内保持最高的成长率。
在预测期内,欧洲地区预计将占据最大的市场份额。这得归功于欧盟绿色交易、严格的建筑材料碳排放法规,以及致力于永续材料创新、前瞻性的建设产业。荷兰、德国、英国和斯堪地那维亚国家拥有最集中的生物材料研究机构、Start-Ups和试点建设计划。政府对生物基建筑创新和循环经济建筑标准的大力公共资金支持,为永续市场发展创造了有利环境。
在预测期内,北美预计将呈现最高的复合年增长率,这主要得益于美国能源部高级研究计划署 (ARPA-E) 和美国能源部 (DOE) 的大量研究经费、大型房地产开发商不断扩大的永续性倡议,以及生医材料领域蓬勃发展的深科技Start-Ups生态系统。美国在菌丝复合材料和生物混凝土技术的研究成果和早期商业性应用方面均处于主导地位。 LEED 和 WELL 建筑认证的日益普及正在创造对创新生物基材料的需求。像 CarbonCure Technologies 这样的公司正在展示商业性可行的发展路径,这鼓励了现有建材公司进行更多投资并进入市场。
According to Stratistics MRC, the Global Living Materials for Construction Market is accounted for $1.1 billion in 2026 and is expected to reach $3.2 billion by 2034 growing at a CAGR of 14.2% during the forecast period. Living materials for construction refer to biologically active building materials engineered through synthetic biology, biotechnology, and advanced material science to perform active functions beyond passive structural roles. These materials include self-healing bio-concrete utilizing bacterial mineralization, mycelium-based composite panels, algae-integrated building skins, carbon-sequestering biocomposites, and bio-engineered structural components that autonomously maintain, repair, or adapt their properties over time. Core functionalities include self-healing capability, carbon capture and storage, thermal regulation, moisture management, and enhanced structural durability across residential, commercial, industrial, and infrastructure construction applications.
Carbon neutrality mandates accelerating bio-material adoption
The construction industry's obligation to decarbonize under national net-zero commitments and international climate agreements is driving serious interest in living materials capable of sequestering carbon and actively reducing embodied emissions in buildings. Concrete production alone accounts for approximately 8% of global CO2 emissions, creating regulatory and market pressure for biocompatible alternatives. Self-healing bio-concrete and carbon-sequestering biocomposites offer compelling sustainability profiles that align with green building certification requirements and investor ESG mandates. Government procurement programs favoring low-carbon building materials and growing corporate net-zero commitments are accelerating the transition from laboratory innovation toward commercial construction deployment.
Scalable manufacturing and quality consistency challenging
Living materials face substantial production scalability challenges that significantly limit their commercial competitiveness relative to conventional construction materials. Biological manufacturing processes for mycelium composites, bacterial concrete, and algae panels require precisely controlled environmental conditions, extended production timelines, and quality consistency challenges that increase manufacturing costs dramatically. Current production volumes are insufficient to meet mainstream construction procurement volumes, creating supply chain risk for large project developers. Achieving the mechanical performance consistency and standardized certification compliance required by building codes and insurance providers remains technically demanding and resource-intensive for early-stage market participants.
Government green construction funding accelerating commercialization
Significant government funding programs in the United States, European Union, United Kingdom, and Singapore are accelerating the commercialization of living construction materials through R&D grants, procurement preference policies, and innovative infrastructure demonstration projects. Programs such as the US ARPA-E bio-inspired building materials initiative and EU Horizon green construction innovation clusters are providing capital and market access critical for bio-material companies at the pre-commercial scale-up stage. Public sector landmark projects incorporating living materials provide visibility, proof-of-concept validation, and procurement credibility that facilitates private sector adoption and attracts subsequent private investment rounds.
Building code approval timelines delaying commercial entry
Building codes and construction material standards in most jurisdictions are designed around traditional inorganic materials with decades of performance data, creating significant certification hurdles for novel biological construction materials. Structural safety authorities require extensive testing evidence, long-term durability data, and standardized performance benchmarks that living materials companies are still accumulating. The multi-year timeline required to achieve building code recognition in key markets delays commercial revenue generation and strains startup financing. Additionally, structural engineering firms and general contractors are conservative adopters who require substantial track records before specifying unproven biological materials in client projects.
COVID-19 reinforced the construction industry's awareness of supply chain vulnerability associated with conventional material dependencies, simultaneously elevating stakeholder focus on sustainable and circular building practices. The pandemic's disruption to traditional material supply chains created receptivity toward locally produced bio-based alternatives with shorter, more resilient supply chains including mycelium composites and bio-concrete systems. Government economic recovery programs in Europe and North America with strong green construction conditions accelerated investment in innovative bio-material R&D and pilot projects. Post-pandemic ESG investment mandates have further elevated institutional interest in living materials as components of net-zero building strategies.
The bacterial mineralization materials segment is expected to be the largest during the forecast period
The bacterial mineralization materials segment is expected to account for the largest market share during the forecast period, owing to their proven, commercially advancing self-healing concrete applications that are achieving regulatory recognition in multiple jurisdictions and attracting substantial construction industry investment. Bacterial mineralization delivers measurable structural repair performance supported by an expanding clinical evidence base, positioning it as the most commercially mature technology within the living materials segment and the leading revenue contributor during the forecast period.
The self-healing capability segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the self-healing capability segment is predicted to witness the highest growth rate, reinforced by intensifying regulatory pressure to reduce lifecycle maintenance costs in public infrastructure and growing demand for autonomous structural repair in applications where manual maintenance is difficult or prohibitively expensive. As climate change accelerates structural stress on buildings and infrastructure, self-healing material functionality is attracting unprecedented investment and specification interest, positioning this functionality segment for the highest growth rate throughout the forecast period.
During the forecast period, the Europe region is expected to hold the largest market share, supported by the EU Green Deal, stringent embodied carbon regulations, and a progressive architectural and construction industry with appetite for sustainable material innovation. The Netherlands, Germany, the United Kingdom, and Scandinavian countries have the highest concentration of living materials research institutions, startup companies, and pilot construction projects. Strong public funding support for bio-based construction innovation and circular economy building standards create a favorable environment for sustained market development.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by substantial ARPA-E and DOE research funding, growing corporate sustainability commitments from major real estate developers, and an active deep-tech startup ecosystem in biomaterials. The United States leads in both research output and early commercial deployment of mycelium composites and bio-concrete technologies. Growing LEED and WELL building certification adoption is creating demand for innovative bio-based materials. Companies such as CarbonCure Technologies have demonstrated commercially viable pathways, encouraging further investment and market entry by established construction materials companies.
Key players in the market
Some of the key players in Living Materials for Construction Market include BASF SE, Holcim Ltd., Heidelberg Materials AG, Saint-Gobain S.A., CEMEX, S.A.B. de C.V., LafargeHolcim Ltd., Skanska AB, CRH plc, Sika AG, Arkema S.A., Dow Inc., Kingspan Group plc, Boral Limited, Ferrovial S.A., Vinci S.A., China State Construction Engineering Corporation, Aditya Birla Group, and CarbonCure Technologies Inc.
In March 2026, BASF launched its BioConstruct AI suite, integrating living polymers with adaptive building materials. The innovation enhances self-healing capacity, reduces maintenance costs, and supports sustainable urban infrastructure through recyclable, high-performance composites.
In February 2026, Holcim unveiled its EcoGrowth Concrete platform, embedding AI-driven microbial modeling into construction workflows. Tailored for green buildings, it improves durability, reduces carbon footprint, and enables scalable deployment in climate-resilient projects.
In January 2026, Heidelberg introduced its SmartBioCement system, combining AI algorithms with bio-mineralization processes. Designed for residential and commercial applications, it accelerates curing, enhances strength, and supports circular economy initiatives in construction.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.